Differential Modulation of N-Type Calcium Channels by mu-Opioid Receptors in Oxytocinergic Versus Vasopressinergic Neurohypophysial Terminals

Department of Physiology & Program in Neuroscience, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.
Journal of Cellular Physiology (Impact Factor: 3.84). 10/2010; 225(1):276-88. DOI: 10.1002/jcp.22263
Source: PubMed


Opioids modulate the electrical activity of magnocellular neurons (MCN) and inhibit neuropeptide release at their terminals in the neurohypophysis. We have previously shown that micro-opioid receptor (MOR) activation induces a stronger inhibition of oxytocin (OT) than vasopressin (AVP) release from isolated MCN terminals. This higher sensitivity of OT release is due, at least in part, to the selective targeting of R-type calcium channels. We now describe the underlying basis for AVP's weaker inhibition by MOR activation and provide a more complete explanation of the complicated effects on neuropeptide release. We found that N-type calcium channels in AVP terminals are differentially modulated by MOR; enhanced at lower concentrations but increasingly inhibited at higher concentrations of agonists. On the other hand, N-type calcium channels in OT terminals were always inhibited. The response pattern in co-labeled terminals was analogous to that observed in AVP-containing terminals. Changes in intracellular calcium concentration and neuropeptide release corroborated these results as they showed a similar pattern of enhancement and inhibition in AVP terminals contrasting with solely inhibitory responses in OT terminals to MOR agonists. We established that fast translocation of Ca(2+) channels to the plasma membrane was not mediating current increments and thus, changes in channel kinetic properties are most likely involved. Finally, we reveal a distinct Ca-channel beta-subunit expression between each type of nerve endings that could explain some of the differences in responses to MOR activation. These results help advance our understanding of the complex modulatory mechanisms utilized by MORs in regulating presynaptic neuropeptide release.

Download full-text


Available from: Govindan Dayanithi
  • Source
    • "A second α-TRP monoclonal antibody was kindly provided by Craig Montell (Johns Hopkins University); both antibodies were tested for specificity in the double mutant trpl;trp. The α-TRPL polyclonal antibody AB5912 was obtained from Chemicon and the pan α-N-type Ca2+ α-1B polyclonal antibody (L-17), from Santa Cruz [47]. Polyclonal antibodies directed against PLC, PKC, INAD [48], [7], Gq-Protein and Rh1 were kindly provided by Charles Zuker (Columbia University). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In Drosophila photoreceptors Ca(2+)-permeable channels TRP and TRPL are the targets of phototransduction, occurring in photosensitive microvilli and mediated by a phospholipase C (PLC) pathway. Using a novel Drosophila brain slice preparation, we studied the distribution and physiological properties of TRP and TRPL in the lamina of the visual system. Immunohistochemical images revealed considerable expression in photoreceptors axons at the lamina. Other phototransduction proteins are also present, mainly PLC and protein kinase C, while rhodopsin is absent. The voltage-dependent Ca(2+) channel cacophony is also present there. Measurements in the lamina with the Ca(2+) fluorescent protein G-CaMP ectopically expressed in photoreceptors, revealed depolarization-induced Ca(2+) increments mediated by cacophony. Additional Ca(2+) influx depends on TRP and TRPL, apparently functioning as store-operated channels. Single synaptic boutons resolved in the lamina by FM4-64 fluorescence revealed that vesicle exocytosis depends on cacophony, TRP and TRPL. In the PLC mutant norpA bouton labeling was also impaired, implicating an additional modulation by this enzyme. Internal Ca(2+) also contributes to exocytosis, since this process was reduced after Ca(2+)-store depletion. Therefore, several Ca(2+) pathways participate in photoreceptor neurotransmitter release: one is activated by depolarization and involves cacophony; this is complemented by internal Ca(2+) release and the activation of TRP and TRPL coupled to Ca(2+) depletion of internal reservoirs. PLC may regulate the last two processes. TRP and TRPL would participate in two different functions in distant cellular regions, where they are opened by different mechanisms. This work sheds new light on the mechanism of neurotransmitter release in tonic synapses of non-spiking neurons.
    Full-text · Article · Aug 2012 · PLoS ONE
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper is the thirty-third consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2010 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology (Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity and neurophysiology (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration (Section 16); and immunological responses (Section 17).
    Full-text · Article · Dec 2011 · Peptides
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Hypothalamic-Neurohypophysial System (HNS) in mammals controls diuresis and parturition through the release of the neuropeptides arginine-vasopressin (AVP) and oxytocin (OT). These neuropeptides are synthesized in hypothalamic Magnocellular neurons (MCNs) and are secreted into the blood stream from terminals in the neurohypophysis (NH). Neuroendocrine function in the HNS is modulated by opioids, either released endogenously or applied exogenously, by acting on μ- or Κ-selective opioid receptors. Parturition is disrupted and the milk ejection reflex is inhibited during lactation when OT release is interrupted by opiate drugs. Also, water and salt balance are regulated by centrally or peripherally administered opioids acting on the HNS. Mu- and kappa- opioid receptors have been identified in the soma and nerve endings of MCN using pharmacological and autoradiographic techniques. When activated in NH terminals, opioid receptors differentially inhibit various types of voltage-gated calcium channels (VGCC), hence modulating the amount of OT and/or AVP being released. In the present research, we characterized the expression of both μ- or Κ-opioid receptors and VGCCs using immunocytochemical techniques and provide evidence for a differential targeting of channels in OT vs. AVP nerve terminals. We propose a model that can explain how opiate effects on VGCCs can directly mediate differences in the control of neurohypophysial OT and/or AVP release.
    Full-text · Chapter · Jan 2012
Show more